News &amp; Updates

Cocoa improves walking performance in elderly patients with peripheral artery disease, according to the results of a phase II trial.

Cocoa confers benefits for walking in older adults with peripheral artery disease

Empagliflozin’s cardiovascular benefits lead the change in T2D treatment paradigm

This second issue revisits the impact EMPA-REG OUTCOME had on clinical practice and helps readers discover how it gives life back to patients through its cardiovascular indication. Learn how it was approved and the possible mechanisms for its cardiovascular benefits.

Empagliflozin’s cardiovascular benefits lead the change in T2D treatment paradigm

Thiazide diuretics may be used in first-line treatment of hypertension in nursing home residents

09 May 2020

Long-term nursing home residents treated for hypertension are less likely to receive and more likely to discontinue treatment with a thiazide diuretic than any other first-line antihypertensive medication, a study reports. However, the drug does not carry an increased risk of incontinence or hospitalization and may thus be a reasonable first-line blood pressure (BP)-lowering treatment choice in this population.

Thiazide diuretics may be used in first-line treatment of hypertension in nursing home residents

09 May 2020

Thrombus aspiration ineffective for STEMI patients

Thrombus aspiration during primary percutaneous coronary intervention does not seem to improve outcomes in patients with ST-elevation myocardial infarction (STEMI), a recent study has found.

Thrombus aspiration ineffective for STEMI patients

Early upstream GPI use in acute myocardial infarction patients potentially harmful

Early upstream use of glycoprotein IIb/IIIa inhibitors (GPIs) in patients with acute myocardial infarction should be avoided even in the presence of an intracoronary thrombotic occlusion, as suggested in a study.

Early upstream GPI use in acute myocardial infarction patients potentially harmful

Tryptophan metabolite kynurenine may be linked to ischaemic heart disease

07 May 2020

There appears to be a possibility that kynurenine, one of the main metabolites of tryptophan, is positively associated with ischaemic heart disease (IHD), but further studies are needed to confirm any link and underlying mechanism, suggests a recent study.

Tryptophan metabolite kynurenine may be linked to ischaemic heart disease

07 May 2020

Polypharmacy in atrial fibrillation linked to several adverse outcomes

06 May 2020

Polypharmacy is highly prevalent among patients with atrial fibrillation and contributes to an increased risk of adverse outcomes, such as all-cause mortality, major bleeding and poorer physical function, among others, according to the results of a meta-analysis.

Polypharmacy in atrial fibrillation linked to several adverse outcomes

06 May 2020

Use of potassium-enriched salt substitutes may reduce CVD deaths

04 May 2020 by

A nationwide intervention to promote the use of potassium-enriched salt substitutes is likely to result in a substantial reduction in deaths from cardiovascular disease (CVD), nonfatal cardiovascular events and disability-adjusted life years in China, suggests a study. Moreover, its benefits seem to outweigh the harms in the overall population and in those with chronic kidney disease (CKD).

Use of potassium-enriched salt substitutes may reduce CVD deaths

Redo-TAVR a safe, effective option for patients with valve dysfunction

Repeat transcatheter aortic valve replacement (redo-TAVR) is relatively safe and effective, making it a feasible alternative for patients with valve dysfunction following TAVR, suggests a study.

Redo-TAVR a safe, effective option for patients with valve dysfunction

DOACs safer than warfarin for atrial fibrillation

In general, direct oral anticoagulants (DOACs) pose less risk of bleeding than do warfarin for the treatment of atrial fibrillation (AF), a new study suggests.

DOACs safer than warfarin for atrial fibrillation